» Articles » PMID: 23514750

A Novel Onco-miR-365 Induces Cutaneous Squamous Cell Carcinoma

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2013 Mar 22
PMID 23514750
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The expression levels of miR-365 vary in different malignancies. Herein, we found that miR-365 was overexpressed in both cells and clinical specimens of cutaneous squamous cell carcinoma (SCC). We demonstrated that the HaCaT(pre-miR-365-2) cell line, which overexpressed miR-365, could induce subcutaneous tumors in vivo. Antagomir-365, an anti-miR-365 oligonucleotide, inhibited cutaneous tumor formation in vivo, along with G1 phase arrest and apoptosis of cancer cells. These findings suggest that miR-365 may act as an onco-miR in cutaneous SCC both in vitro and in vivo. The present study provides valuable insight into the role of miR-365 in cutaneous SCC formation, which can help develop new drug and miR-365 target-based therapies for cutaneous SCC.

Citing Articles

Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions.

Conley J, Genenger B, Ashford B, Ranson M Int J Mol Sci. 2024; 25(15).

PMID: 39126067 PMC: 11313315. DOI: 10.3390/ijms25158493.


Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.

Hua X, Xiang D, Guo M, Qian X, Chen R, Li T Cell Death Dis. 2022; 13(8):753.

PMID: 36045117 PMC: 9433410. DOI: 10.1038/s41419-022-05205-w.


MicroRNA-365a/b-3p as a Potential Biomarker for Hypertrophic Scars.

Lee J, Kim G, Lee J, Ryu J, Oh E, Kim H Int J Mol Sci. 2022; 23(11).

PMID: 35682793 PMC: 9181131. DOI: 10.3390/ijms23116117.


Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.

Hedberg M, Berry C, Moshiri A, Xiang Y, Yeh C, Attilasoy C Int J Mol Sci. 2022; 23(7).

PMID: 35408839 PMC: 8998533. DOI: 10.3390/ijms23073478.


CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity.

Kelemen A, Carmi I, Seress I, Lorincz P, Tolgyes T, Dede K Int J Mol Sci. 2022; 23(4).

PMID: 35216292 PMC: 8879498. DOI: 10.3390/ijms23042180.


References
1.
Ding Z, Zhou J, Wei W, Baker V, Wu G . Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines. Oncogene. 2002; 21(29):4530-8. DOI: 10.1038/sj.onc.1205545. View

2.
Zhao Y, Srivastava D . A developmental view of microRNA function. Trends Biochem Sci. 2007; 32(4):189-97. DOI: 10.1016/j.tibs.2007.02.006. View

3.
Shu M, Zhou Y, Zhu W, Zhang H, Wu S, Chen J . MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway. Mol Pharmacol. 2011; 81(3):292-8. DOI: 10.1124/mol.111.076166. View

4.
Qin B, Xiao B, Liang D, Xia J, Li Y, Yang H . MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun. 2011; 410(1):127-33. DOI: 10.1016/j.bbrc.2011.05.118. View

5.
Persson M, Andren Y, Mark J, Horlings H, Persson F, Stenman G . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009; 106(44):18740-4. PMC: 2773970. DOI: 10.1073/pnas.0909114106. View